annual cash & cash equivalents:
$118.04M+$73.67M(+166.06%)Summary
- As of today (August 22, 2025), PLSE annual cash & cash equivalents is $118.04 million, with the most recent change of +$73.67 million (+166.06%) on December 31, 2024.
- During the last 3 years, PLSE annual cash & cash equivalents has risen by +$89.42 million (+312.52%).
- PLSE annual cash & cash equivalents is now at all-time high.
Performance
PLSE Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$106.35M-$12.93M(-10.84%)Summary
- As of today (August 22, 2025), PLSE quarterly cash & cash equivalents is $106.35 million, with the most recent change of -$12.93 million (-10.84%) on June 30, 2025.
- Over the past year, PLSE quarterly cash & cash equivalents has increased by +$80.15 million (+305.97%).
- PLSE quarterly cash & cash equivalents is now -10.84% below its all-time high of $119.28 million, reached on March 31, 2025.
Performance
PLSE quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
PLSE Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +166.1% | +306.0% |
| 3 y3 years | +312.5% | +618.7% |
| 5 y5 years | +1610.9% | +181.6% |
PLSE Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +312.5% | -10.8% | +618.7% |
| 5 y | 5-year | at high | +1610.9% | -10.8% | +739.0% |
| alltime | all time | at high | +5550.4% | -10.8% | +4952.2% |
PLSE Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $106.35M(-10.8%) |
| Mar 2025 | - | $119.28M(+1.1%) |
| Dec 2024 | $118.04M(+166.1%) | $118.04M(+49.4%) |
| Sep 2024 | - | $79.03M(+201.7%) |
| Jun 2024 | - | $26.20M(-24.9%) |
| Mar 2024 | - | $34.88M(-21.4%) |
| Dec 2023 | $44.37M(-27.4%) | $44.37M(-11.9%) |
| Sep 2023 | - | $50.39M(-14.2%) |
| Jun 2023 | - | $58.75M(+8.6%) |
| Mar 2023 | - | $54.10M(-11.5%) |
| Dec 2022 | $61.14M(+113.7%) | $61.14M(-11.6%) |
| Sep 2022 | - | $69.16M(+367.4%) |
| Jun 2022 | - | $14.80M(+16.7%) |
| Mar 2022 | - | $12.68M(-55.7%) |
| Dec 2021 | $28.61M(+129.6%) | $28.61M(-31.9%) |
| Sep 2021 | - | $41.99M(-11.5%) |
| Jun 2021 | - | $47.43M(-20.8%) |
| Mar 2021 | - | $59.88M(+192.5%) |
| Dec 2020 | $12.46M | $20.48M(-30.8%) |
| Sep 2020 | - | $29.59M(-21.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $37.77M(+137.7%) |
| Mar 2020 | - | $15.89M(-37.5%) |
| Dec 2019 | $6.90M(-86.5%) | $25.40M(-26.4%) |
| Sep 2019 | - | $34.50M(-19.1%) |
| Jun 2019 | - | $42.64M(-19.2%) |
| Mar 2019 | - | $52.80M(-11.4%) |
| Dec 2018 | $51.10M(+1409.2%) | $59.58M(+183.4%) |
| Sep 2018 | - | $21.02M(-23.6%) |
| Jun 2018 | - | $27.50M(-17.6%) |
| Mar 2018 | - | $33.38M(-12.3%) |
| Dec 2017 | $3.39M(+62.1%) | $38.07M(-9.4%) |
| Sep 2017 | - | $42.04M(+173.0%) |
| Jun 2017 | - | $15.40M(-18.4%) |
| Mar 2017 | - | $18.86M(+15.0%) |
| Dec 2016 | $2.09M(-42.1%) | $16.39M(-12.4%) |
| Sep 2016 | - | $18.71M(-9.6%) |
| Jun 2016 | - | $20.71M(+883.8%) |
| Mar 2016 | - | $2.10M(-41.6%) |
| Dec 2015 | $3.61M(-48.5%) | $3.61M |
| Dec 2014 | $7.01M | - |
FAQ
- What is Pulse Biosciences, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Pulse Biosciences, Inc.?
- What is Pulse Biosciences, Inc. annual cash & cash equivalents year-on-year change?
- What is Pulse Biosciences, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Pulse Biosciences, Inc.?
- What is Pulse Biosciences, Inc. quarterly cash & cash equivalents year-on-year change?
What is Pulse Biosciences, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of PLSE is $118.04M
What is the all time high annual cash & cash equivalents for Pulse Biosciences, Inc.?
Pulse Biosciences, Inc. all-time high annual cash & cash equivalents is $118.04M
What is Pulse Biosciences, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, PLSE annual cash & cash equivalents has changed by +$73.67M (+166.06%)
What is Pulse Biosciences, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of PLSE is $106.35M
What is the all time high quarterly cash & cash equivalents for Pulse Biosciences, Inc.?
Pulse Biosciences, Inc. all-time high quarterly cash & cash equivalents is $119.28M
What is Pulse Biosciences, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, PLSE quarterly cash & cash equivalents has changed by +$80.15M (+305.97%)